Sunshine Biopharma, Inc Business Finance Contracts & Agreements
33 Contracts & Agreements
- Financing Agreements (2 contracts)
- Investment Agreements (1)
- Note Agreements (1)
- Purchase Agreements (7)
- Registration Rights Agreements (5)
- Share Agreements (2)
- Underwriting Agreements (3)
- Warrant Agreements (12)
- Form of Pre-Funded Warrant (Filed With SEC on May 16, 2023)
- Form of Registration Rights Agreement (Filed With SEC on May 16, 2023)
- Form of Warrant (Filed With SEC on May 16, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on May 16, 2023)
- Share Purchase Agreement between Sunshine Biopharma, Inc., Malek Chamoun and Nora Pharma Inc (Filed With SEC on October 20, 2022)
- Form of Warrant (Filed With SEC on April 28, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on April 28, 2022)
- Form of Registration Rights Agreement (Filed With SEC on April 28, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on April 28, 2022)
- Form of Warrant (Filed With SEC on March 15, 2022)
- Form of Registration Rights Agreement (Filed With SEC on March 15, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on March 15, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on March 15, 2022)
- Warrant Agency Agreement between Sunshine Biopharma, Inc. and Equiniti Trust Company, dated February 17, 2022 (Filed With SEC on February 17, 2022)
- Underwriting Agreement between Sunshine Biopharma, Inc. and Aegis Capital Corp., dated February 15, 2022 (Filed With SEC on February 17, 2022)
- Form of Warrant (Filed With SEC on February 17, 2022)
- Form of Warrant for offering (Filed With SEC on February 14, 2022)
- Form of Underwriting Agreement (Filed With SEC on February 14, 2022)
- Form of Warrant Agent Agreement (Filed With SEC on February 9, 2022)
- Form of Underwriting Agreement (Filed With SEC on February 9, 2022)
- Form of Warrant for offering (Filed With SEC on February 9, 2022)
- Form of Pre-Funded Warrant for offering (Filed With SEC on February 9, 2022)
- Financing Agreement with RB Capital Partners, Inc (Filed With SEC on September 15, 2020)
- Share Transfer Agreement with Atlas Pharma Inc., et al (Filed With SEC on July 19, 2019)
- Registration Rights Agreement dated September 10, 2018 by and between Sunshine Biopharma, Inc. and GHS Investments, LLC (Filed With SEC on September 14, 2018)
- Equity Financing Agreement dated September 10, 2018 by and between Sunshine Biopharma, Inc. and GHS Investments, LLC (Filed With SEC on September 14, 2018)
- Promissory Note issued by Sunshine Biopharma, Inc. in favor of GHS Investments LLC (Filed With SEC on September 14, 2018)
- AMENDMENT NO. 1 TO PATENT PURCHASE AGREEMENT By and Between SUNSHINE BIOPHARMA, INC. And ADVANOMICS CORPORATION Dated as of March 14, 2016 (Filed With SEC on March 14, 2016)
- AMENDMENT NO. 1 TO PATENT PURCHASE AGREEMENT By and Between SUNSHINE BIOPHARMA, INC. And ADVANOMICS CORPORATION Dated as of March 14, 2016 (Filed With SEC on March 14, 2016)
- Patent Purchase Agreement with Advanomics Corporation (Filed With SEC on December 28, 2015)
- PATENT PURCHASE AGREEMENT By and Between SUNSHINE BIOPHARMA, INC. And ADVANOMICS CORPORATION Dated as of October 8, 2015 PATENT PURCHASE AGREEMENT (Filed With SEC on October 9, 2015)
- INVESTMENT AGREEMENT (Filed With SEC on April 28, 2014)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 28, 2014)
